During the past decade, Hôpital Pierre Paul Riquet conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 3 clinical trials were completed, i.e. on average, 10.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 3 clinical trials were completed. i.e. 27.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Pierre Paul Riquet" #1 sponsor was "Allotex, Inc." with 3 trials, followed by "Assistance Publique - Hôpitaux de Paris" with 2 trials sponsored, "Centre Hospitalier Universitaire de Saint Etienne" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Fondation Ophtalmologique Adolphe de Rothschild" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Pierre Paul Riquet" #1 collaborator was "ClinSearch" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Centre Hospitalier St Anne" with 1 trials as a collaborator and "Centre National de la Recherche Scientifique, France" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Pierre Paul Riquet" are "Benign Neuronal Desease" (2 trials), "Parkinson Disease" (2 trials), "Presbyopia" (2 trials), "Rheumatoid Arthritis" (2 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Hôpital Pierre Paul Riquet" in a lesser frequency.

Most popular intervention types in "Hôpital Pierre Paul Riquet" are "Drug" (12 trials), "Other" (11 trials), "Device" (4 trials), "Procedure" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "cerebral MRI" (2 trials), "Adalimumab" (1 trials), "Administering diagnosis orientation questionnaires for the screening of possible sleep disorders" (1 trials) and "Antiplatelet therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Pierre Paul Riquet" are 28 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Pierre Paul Riquet". 1 are not yet recruiting, 10 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Hôpital Pierre Paul Riquet, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Pierre Paul Riquet, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 8 trials that are defined as “Not Applicable".